Search - tctmd.com

Displaying 1 - 20 of 104

Sort: Relevancy | Date

News Conference News

Watchman, Amulet LAA Closure Devices Carry Low Complication Rates

Todd Neale

November 04, 2016

Presentation TCT 2016

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Presenter: Martin B. Leon, Louis A. Cannon, David R. Holmes Jr.

November 02, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Todd Neale

November 02, 2016

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Management of Residual Leaks After LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw

November 01, 2016

Presentation TCT 2016

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw

November 01, 2016

Presentation TCT 2016

Follow-up Evaluation After LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw, Bushra S Rana

November 01, 2016

Presentation TCT 2016

Iatrogenic ASD After Transeptal Interventions: Frequency, Impact, and Treatment (If Any)

Presenter: Lee N. Benson, Ziyad M. Hijazi, David R. Holmes Jr.

November 01, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

Presentation TCT 2016

TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Firas Zahr

October 31, 2016

Presentation TCT 2016

TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, shantanu Deshpande

October 31, 2016

Presentation TCT 2016

TCT 1492: Double Valve Case TAVR and TMVR in Native Annulus at the Same Time

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, M. Rizwan Sardar

October 31, 2016

Presentation TCT 2016

TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Farzin Beygui

October 31, 2016

Presentation TCT 2016

Strengths and Limitations of Post-Approval Registries as Vehicles to Track Safety and Inform Device Label Expansion

Presenter: Owen Faris, Mitchell W. Krucoff, David R. Holmes Jr.

October 31, 2016

News Conference News TCT 2016

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Brian K. Whisenant

October 30, 2016

Advertisement

Watchman, Amulet LAA Closure Devices Carry Low Complication Rates

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Management of Residual Leaks After LAA Closure

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure

Follow-up Evaluation After LAA Closure

Iatrogenic ASD After Transeptal Interventions: Frequency, Impact, and Treatment (If Any)

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves

TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder

TCT 1492: Double Valve Case TAVR and TMVR in Native Annulus at the Same Time

TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient

Strengths and Limitations of Post-Approval Registries as Vehicles to Track Safety and Inform Device Label Expansion

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content